James Carthew: I’m confident my biotech casualties will recover
Our columnist hangs on to Biotech Growth and Syncona despite their woeful five-year returns, hopeful a combination of self-help and postive fundamentals will spark a rebound.
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
Our columnist hangs on to Biotech Growth and Syncona despite their woeful five-year returns, hopeful a combination of self-help and postive fundamentals will spark a rebound.
US activist Saba Capital makes its first public move in the UK investment company sector, threatening to vote against the continuation of the Alexander Darwall managed trust next month.
Fidelity fund manager Nitin Bajaj explains why the Chinese jewellery chain is a top 10 position in his portfolio.
Growth stock ratings stand at an all-time high versus value stocks in Asia, and that has got to change, says Fidelity fund manager Nitin Bajaj.
Fidelity Asian Values fund manager explains why smaller value companies have been the region's best performers in the past thirty years.
Paul Daggett of NB Private Equity explains how small ‘roll-up’ deals and big strategic acquisitions are driving the underlying returns of private equity funds.
Impax Environmental Markets employed three private placement debt notes and a new credit facility to bring its borrowing up to 7%.
Abrdn Asia veteran Hugh Young steps down from investment trust and prepares to leave funds group at end of the year.
Activist investor Metage Capital urges investors in Hipgnosis Songs to vote against the re-election of half its board at next week's annual general meeting.
The discount on the private equity trust refuses to budge despite ongoing strong performance.
Mercantile is passing on its revenue to shareholders with an increased dividend payment.
VinaCapital Vietnam Opportunities has almost a quarter of its portfolio in financials.
Developed by Moore-Wilson